Skip to main content
Clinical Trials/NCT05619822
NCT05619822
Enrolling by Invitation
N/A

A Comprehensive Third-generation Intervention for People With Psychosis and Post-traumatic Stress Symptoms; Design, Implementation and Effectiveness

Universidad Complutense de Madrid1 site in 1 country100 target enrollmentMay 27, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Trauma, Psychological
Sponsor
Universidad Complutense de Madrid
Enrollment
100
Locations
1
Primary Endpoint
Change from psychopathological symptoms at 12 weeks and 6 months
Status
Enrolling by Invitation
Last Updated
last year

Overview

Brief Summary

Existing data suggest that both trauma and Post-Traumatic Stress Disorder (PTSD) are very common among individuals with psychosis. The presence of PTSD symptoms in psychosis is associated with worse clinical outcomes and poorer social functioning. However, PTSD is a poorly attended and poorly studied condition among this population. Research to date indicates that trauma-focused treatments are safe and effective for PTSD, even when psychotic comorbidity is present. Recent systematic reviews of psychological interventions for trauma in psychosis found that are effective in reducing trauma symptoms, suggesting that they should be implemented in front-line services. Nonetheless, larger confirmative trials are required to form robust conclusions.The aim of this project is to examine the efficacy of comprehensive third-generation protocol for people with comorbid trauma and psychosis.

Detailed Description

This study is a randomized clinical trial at psychiatric rehabilitation services of the Public Network of Care for people with serious mental disorders. We hypothesize that participants receiving the intervention, in comparison with controls, will show a reduction in general, PTSD and psychotic symptomatology, an improvement in levels of functioning and well-being, a greater ability to regulate emotions with more help-seeking behaviours. Given the complexity of both psychosis and PTSD and the reluctance of professionals to treat it, we plan to develop a precise comprehensive protocol. In order to address all issues associated with both psychosis and comorbid PTSD, the protocol will be developed following the three stages of recovery from trauma: first, focusing on establishing the therapeutic alliance and safety; second, focusing on recounting and re-processing the traumatic event; and third, focusing on reconnecting with others and with life despite the trauma experienced. The therapy will be adapted to the characteristics of people with SMD and administered in 11 90-minute individual sessions per week, combining strategically ACT, Mindfulness, EMDR as well as Positive Psychology interventions.

Registry
clinicaltrials.gov
Start Date
May 27, 2022
End Date
July 30, 2026
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Those showing a high risk of PTSD (TSQ ≥6) will be further evaluated to determine whether they meet the inclusion criteria. Participants must:
  • Be between the ages of 18 and 65 fluent enough in Spanish language;
  • Meet the criteria for a diagnosis of a psychotic spectrum disorder or a mood disorder with psychotic symptoms according to MINI (Sheeman et al., 1997);
  • Meet PTSD diagnostic criteria according to the Clinician-Administered PTSD Scale (CAPS; Blake et al., 1995)

Exclusion Criteria

  • Those who have a diagnosis of substance or alcohol abuse or dependence in the 30 days prior to participation in the study
  • To have a severe neurocognitive problems or brain damage that interfere with the basic processing of information in psychotherapy.

Outcomes

Primary Outcomes

Change from psychopathological symptoms at 12 weeks and 6 months

Time Frame: Change baseline, 12 weeks, and 6 months

Symptom Checklist 45-SCL-90_r brief (Davison et al., 1997). Higher scores mean a worse outcome.

Change from posttraumatic symptoms at 12 weeks and 6 months

Time Frame: Change baseline, 12 weeks, and 6 months

International Trauma Questionnaire (ITQ; Cloitre, et al., 2018).Higher scores mean a worse outcome.

Change from psychotic symptoms at 12 weeks and 6 months

Time Frame: Change baseline, 12 weeks, and 6 months

Psychotic Symtoms Rating Scale (Haddock et al., 1999).Higher scores mean a worse outcome.

Change from dissociative symptoms at 12 weeks and 6 months

Time Frame: Change baseline, 12 weeks, and 6 months

The Dissociative Experience Scale Taxon (DES-T; Waller \& Ross, 1997). Higher scores mean a worse outcome.

Secondary Outcomes

  • Change from Wellbeing at 12 weeks and 6 months(Change baseline, 12 weeks, and 6 months)
  • Change from Attachment at 12 weeks and 6 months(Change baseline, 12 weeks, and 6 months)
  • Change from Personal and Social functioning at 12 weeks and 6 months(Change baseline, 12 weeks, and 6 months)
  • Change from Emotion Regulation at 12 weeks and 6 months(Change baseline, 12 weeks, and 6 months)
  • Change from satisfaction with life at 12 weeks and 6 months(Change baseline, 12 weeks, and 6 months)

Study Sites (1)

Loading locations...

Similar Trials